Methylene blue: Revisited

Journal of Anaesthesiology Clinical Pharmacology

Volumn 26, Issue 4, 2010, Pages 517-520

  Ginimuge, Prashant R ^a   Jyothi, S D ^a  

^a Belgaum Institute of Medical Sciences   (India)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84872129813     PISSN: 09709185     EISSN: 22312730     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Bosoy, Dimitry, Axelband, et al. Utilization of methylene blue in the setting of hypotension associated with concurrent renal and hepatic failure: a concise review. OPUS 12 Scientist 2008; 2: 21-9.
2. Peter schenk, Christian Madl, Shahrzad Rezaie-Majd, Stephen Lehr, Christian Muller. Methylene blue improves the hepatopulmonary syndrome. Ann Intern Med 2000; 133: 701-6.
3. Preiser, Jean-Charles, Lejeune, et al. Methylene blue administration in septic shock: A Clinical Trial. Critical Care Medicine 1995; 23: 259-64.
4. Ertugrul Ozal, Erkan Kuralay, Vedat Yildirim, et al. Preoperative methylene blue administration in patients at high risk for vasoplegic syndrome during cardiac surgery. Ann Thorac Surg 2005; 79: 1615-9.
5. Armand Mekontso-Dessap, Remi Houel, Celine Soustelle, Matthias Kirsch, Dominique Thebert, Daniel Y.Loisance. Risk factors for post-cardiopulmonary bypass vasoplegia in patients with preserved left ventricular function. Ann Thorac Surg 2001; 71: 1428-32.
6. Tuman KJ, McCarthy RJ, O'Connor CJ, Holm WE, Ivankovich AD. Angiotensin-converting enzyme inhibitors increase vasoconstrictor requirements after cardiopulmonary bypass.Anesth Analg 1995; 80: 473-9.
7. Reiner G. Leyh, Theo Kofidis, Martin Struber,et al. Methylene Blue: The drug of choice for catecholamine-refractory vasoplegia after cardiopulmonary bypass?. J Thorac Cardiovasc Surg 2003; 125: 1426-31.
8. Ricardo L. Levin, Marcela A. Degrange, Gustavo F. Bruno, et al. Methylene blue reduces mortality and morbidity in vasoplegic patients after cardiac surgery. Ann Thorac Surg 2004; 77: 496-9.
9. B. Gachot, J.P. Bedos, B.Veber, M. Wolff, B. Regnier. Short-term effects of methylene blue on hemodynamics and gas exchange in humans with septic shock. Intensive Care Medicine 1995; 21: 1027-31.
10. M.Grayling, C. D.Deakin. Methylene blue during cardiopulmonary bypass to treat refractory hypotension in septic endocarditis. J Thorac Cardiovasc Surg 2003; 125: 426-7.
11. T. Kofidis, M. Struber, M. Wilhelmi, et al. Reversal of severe vasoplegia with single-dose methylene blue after heart transplantation. J Thoracic Cardiovasc Surg 2001; 122: 823-4.
12. Evora PRB, Riberio PJF, Andrade JCS. Methylene blue administration in SIRS after cardiac operations. Ann Thorac Surg 1997; 63; 12-3.
13. Moritoki Egi, Rinaldo Bellomo, Christoph Langenberg, et al. selecting a vasopressor drug for vasoplegic shock after adult cardiac surgery: A systematic literature review. Ann Thorac Surg 2007; 83: 715-23.
14. Edmund S. H. Kwok, Daniel Howes. Use of methylene blue in sepsis: A Systematic Review. Journal of Intensive Care Medicine 2006; 21: 359-63.
15. Peter E Meissner, Germain Mandi, Boubacar Coulibaly, et al. Methylene blue for malaria in Africa: results from a dose-finding study in combination with chloroquine. Malaria Journal 2006; 5: 84.
16. Schirmer R.H, Coulibaly B, Stich A, et al. Methylene blue as an antimalarial agent. Redox rep 2003; 8: 272-5.
17. Marianne Boylston, Deborah Beer. Methemoglobinemia: A Case Study. Critical Care Nurse 2002; 22: 50-5.
18. Clifton, Jack II, Leikin, Jerrold. Methylene blue. American Journal of Therapeutics 2003; 10: 289-91.
19. Wondrak GT. NQO1-activated phenothiazinium redox cyclers for the targeted bioreductive induction of cancer cell apoptosis. Free Radic Biol Med 2007; 43: 178-90.
20. Alici-Evcimen Y, Breitbart WS. Ifosfamide neuropsychiatric toxicity in patients with cancer. Psychooncology 2007; 16: 956-60.
21. J Pelgrims, F De Vos, J Van den Brande, D Schrijvers, Prove, JB Vermorken. Methylene blue in the treatment and prevention of ifosfamide-induced encephalopathy: report of 12 cases and a review of the literature. British Journal of Cancer 2000; 82: 291-4.
22. Donald L.Gordan, Mohan C.Airan, William Thomas, Leon H. Seidman. Parathyroid identification by methylene blue infusion. British Journal of Surgery 2005; 62: 747-9.
23. R.I. Beretvas, J. Ponsky. Endoscopic marking: an adjunct to laparoscopic gastrointestinal surgery. Surgical endoscopy 2001; 15: 1202-3.
24. Simmons RM, Smith SM, Osborne MP. Methylene blue dye as an alternative to isosulfan blue dye for sentinel lymph node localization. Breast J 2001; 7: 181-3.
25. V. Misra, SP Misra, M. Dwivedi, SC Gupta. The Loeffler's methylene blue stain: An inexpensive and rapid method for detection of helicobacter pylori. Journal of Gastroenterology and Hepatology 2008; 9; 512-3.
26. Sloand EM, Kessler CM, Mcintosh CL, Klein HG. Methylene blue for neutralization of heparin. Thromb Res 1989; 54: 677-86.
27. Steers WD, Selby JB. Use of methylene blue and selective embolization of the pudendal artery for high flow priapism refractory to medical and surgical treatments. J Urol 1991; 146: 1361-3.
28. Murat Oz, Dietrich E. Lorke, George A. Petroianu. Methylene blue and Alzheimer's disease. Biochemical pharmacology 2009; 78: 927-32.
29. Parjam S Zolfaghari, Samantha Packer, Mervyn Singer, et al. In vivo killing of Staphylococcus aureus using light-activated antimicrobial agent. BMC Microbiology 2009; 9: 27.
30. Muller-Breitkreutz, Mohr H. Hepatitis C and human immunodeficiency virus RNA degradation by methylene blue/light treatment of human plasma. J Med Virol 1998; 56: 239-45.
31. Salah M, Samy N, Fadel M. Methylene blue mediated photodynamic therapy for resistant plaque psoriasis. J Drugs Dermatol 2009; 8: 42-9.
32. M Salhab, W Al sarakbi, K Mokbel. Skin and fat necrosis of the breast following methylene blue dye injection for sentinel node biopsy in a patient with breast cancer. Int Semin Surg Oncol. 2005; 2: 26.
33. Cowett RM, Hakanson DO, Kocon RW, Oh W. Untoward neonatal effect of intraamniotic administration of methylene blue. Obstet Gynecol 1976; 48:74-5.
34. Crooks J. Haemolytic jaundice in a neonate after intra¬amniotic injection of methylene blue. Arch Dis Child 1982; 57: 872-3.
35. Fish WH, Chazen EM. Toxic effects of methylene blue on the fetus. Am J Dis Child 1992; 146: 1412-3.
36. Plunkett GD. Neonatal complications. Obstet Gynecol 1973; 41: 476-7.
37. Porat R, Gilbert S, Magilner D. Methylene blue-induced phototoxicity: An unrecognized complication. Pediatrics 1996; 97: 717-21.
38. Serota FT, Bernbaum JC, Schwartz E. The methylene-blue baby. Lancet 1979; 2: 1142-3.
39. Spahr RC, Salsburey DJ, Krissberg A, Prin W. Intraamniotic injection of methylene blue leading to methemoglobinemia in one of twins. Int J Gynaecol Obstet 1980; 17: 477-8.
40. Troche Bl. The methylene blue baby. N Engl J Med 1989; 320: 1756-7.
41. Vincer MJ, Allen AC, Evans JR, Nwaesei C, Stinson DA. Methylene-blue-induced hemolytic anemia in a neonate. Can Med Assoc J 1987; 136: 503-4.
42. Gillman P K. Methylene blue implicated in potentially fatal serotonin toxicity. Anaesthesia 2006; 61: 1013-4.
43. Pascale Dewachter, Claudie Moutan-Faivre, Philippe Trechot, Jean-Claude Lieu, Paul Michel Mertes. Severe anaphylactic shock with methylene blue instillation. Anesth Analg 2005; 101: 149-50.